Literature DB >> 30204428

Detection of Infantile Batten Disease by Tandem Mass Spectrometry Assay of PPT1 Enzyme Activity in Dried Blood Spots.

Hamid Khaledi1, Yang Liu1, Sophia Masi1, Michael H Gelb1.   

Abstract

A new tandem mass spectrometry (MS/MS)-based approach for measurement of the enzymatic activity of palmitoyl protein thioesterase I (PPT1) in dried blood spots (DBS) is presented. Deficiency in this enzyme leads to infantile neuronal ceroid lipofuscinosis (INCL, Infantile Batten disease, CLN1). The assay could distinguish between 80 healthy newborns and three previously diagnosed INCL patients. Unlike the fluorimetric PPT1 assay, the MS/MS assay does not require recombinant β-glucosidase. Furthermore, the assay could be easily combined with a TPP1 enzyme assay (for CLN2 disease) and can be potentially multiplexed with a large panel of additional lysosomal enzyme assays by MS/MS for newborn screening and postscreening analysis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30204428      PMCID: PMC6423508          DOI: 10.1021/acs.analchem.8b03188

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   8.008


  17 in total

1.  Rapid and simple assay for the determination of tripeptidyl peptidase and palmitoyl protein thioesterase activities in dried blood spots.

Authors:  Zoltan Lukacs; Pirkko Santavuori; Angelika Keil; Robert Steinfeld; Alfried Kohlschütter
Journal:  Clin Chem       Date:  2003-03       Impact factor: 8.327

Review 2.  Thematic review series: lipid posttranslational modifications. Lysosomal metabolism of lipid-modified proteins.

Authors:  Jui-Yun Lu; Sandra L Hofmann
Journal:  J Lipid Res       Date:  2006-04-20       Impact factor: 5.922

Review 3.  Experimental therapies in the neuronal ceroid lipofuscinoses.

Authors:  Nicole J Neverman; Hannah L Best; Sandra L Hofmann; Stephanie M Hughes
Journal:  Biochim Biophys Acta       Date:  2015-05-06

Review 4.  Neuronal ceroid lipofuscinoses.

Authors:  Brigitte Chabrol; Catherine Caillaud; Berge Minassian
Journal:  Handb Clin Neurol       Date:  2013

5.  A rapid fluorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL.

Authors:  O P van Diggelen; J L Keulemans; B Winchester; I L Hofman; S L Vanhanen; P Santavuori; Y V Voznyi
Journal:  Mol Genet Metab       Date:  1999-04       Impact factor: 4.797

Review 6.  Cerliponase Alfa: First Global Approval.

Authors:  Anthony Markham
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

7.  The crystal structure of palmitoyl protein thioesterase-2 (PPT2) reveals the basis for divergent substrate specificities of the two lysosomal thioesterases, PPT1 and PPT2.

Authors:  Guillermo Calero; Praveena Gupta; M Cristina Nonato; Sagun Tandel; Edward R Biehl; Sandra L Hofmann; Jon Clardy
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

Review 8.  Neuronal ceroid-lipofuscinoses in childhood.

Authors:  P Santavuori
Journal:  Brain Dev       Date:  1988       Impact factor: 1.961

Review 9.  Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis.

Authors:  Ryan D Geraets; Seung yon Koh; Michelle L Hastings; Tammy Kielian; David A Pearce; Jill M Weimer
Journal:  Orphanet J Rare Dis       Date:  2016-04-16       Impact factor: 4.123

10.  Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses.

Authors:  Ni Sima; Rong Li; Wei Huang; Miao Xu; Jeanette Beers; Jizhong Zou; Steven Titus; Elizabeth A Ottinger; Juan J Marugan; Xing Xie; Wei Zheng
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.303

View more
  1 in total

1.  The LINCE Project: A Pathway for Diagnosing NCL2 Disease.

Authors:  Daniel Rodrigues; Maria José de Castro; Pablo Crujeiras; Anna Duat-Rodriguez; Ana Victoria Marco; Mireia Del Toro; María L Couce; Cristóbal Colón
Journal:  Front Pediatr       Date:  2022-03-29       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.